Shares of Torrent Pharmaceuticals rallied over 5% in early trade on February 16, 2026 (IST) after the company reported strong consolidated earnings for the third quarter. The stock touched a fresh 52-week high during the session, supported by double-digit growth in revenue, EBITDA and net profit on a year-on-year basis.
As of 9:28 AM IST, Torrent Pharma’s stock surged to an intraday high of Rs 4,293.90, compared to the previous close of Rs 4,078.00. The stock opened at Rs 4,144.30 and slipped to a low of Rs 4,118.00 during the morning trade. Notably, the day’s high of Rs 4,293.90 also marked its new 52-week high, surpassing the earlier peak, while the 52-week low stands at Rs 2,886.45.
For Q3 FY26, the company reported consolidated revenue of Rs 3,303 crore, up 17.6% from Rs 2,809 crore in the corresponding quarter last year. EBITDA rose 19.0% year-on-year to Rs 1,088 crore, compared with Rs 914 crore in Q3 FY25. EBITDA margin improved by 40 basis points to 32.9% from 32.5% a year ago, reflecting operational efficiency and improved cost management.
Net profit for the quarter jumped 26.2% to Rs 635 crore, as against Rs 503 crore in the year-ago period, indicating strong bottom-line expansion backed by healthy operating performance.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.